Learn more

HIPRA LAB SA

Overview
  • Total Patents
    46
About

HIPRA LAB SA has a total of 46 patent applications. Its first patent ever was published in 1993. It filed its patents most often in Spain, EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are BOEHRINGER INGELHEIM CORP, FOND TELETHON and VALENTIS INC.

Patent filings per year

Chart showing HIPRA LAB SAs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Espuna Maso Enric 17
#2 Pinol Ribas Jaume 12
#3 Querol Murillo Enrique 12
#4 Bru Virgili Sergi 10
#5 Alemany Burch Reina 7
#6 Querol Enrique 6
#7 Riera Pujadas Pere 6
#8 Saubi Roca Narcis 6
#9 Pinol Jaume 4
#10 Lloberas Jorge 4

Latest patents

Publication Filing date Title
CN104685057A Mutant strains of mycoplasma hyopneumoniae
EP2684959A1 Vectors for transforming Mycoplasma hyopneumoniae, transformed M.hyopneumoniae strains, and use thereof
ES2416154A1 live attenuated strain of Actinobacillus pleuropneumoniae
WO2007039070A2 Polynucleotides of haemophilus parasuis and its use
ES2319242A1 ISOLATED AVIRULENT OF NEOSPORA CANIMUM AND ITS USES.
ES2233145A1 LIVED VACCINE ATTENATED AGAINST SWINE PLEURONEUMONIA.
ES2129342A1 "formulation of liposomal vaccines and their preparation".
ES2127692A1 Formulation of enrofloxacin in liposomes and its preparation.
ES2102971A1 New attenuated strain of the virus causing the respiratory and reproductive syndrome (prrs), the vaccines and diagnostic media obtainable with the same and the procedures for its obtaining.
ES2092960A1 Gene of actinobacillus pleuropneumoniae transferrine union protein 1 (tbp1), use of this in the preparation of products for pleuronomonia vaccination and in diagnostic reagents.
ES2088371A1 Procedure for the recombinant production of antigens of the glycoprotein ge of bovine herpesvirus type 1 and its use in the serological differentiation between infected animals and vaccinated animals.
ES2074965A1 Recombinant mutant viruses of infectious bovine rhinotracheitis and vaccines that contain it.
ES2070774A1 Liposomic preparations of drugs or vaccine antigens for veterinary medicine.
ES2053402A1 Preparation method for inactivated vaccines and adjuvant living vaccines as well as vaccines obtained by such method.